Pharmaron Beijing Co., Ltd. (300759.SZ)
CNY 23.08
(1.58%)
CNY 23.08
(1.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.84 Billion CNY | -0.01% |
| 2022 | 1.68 Billion CNY | -11.72% |
| 2021 | 1.91 Billion CNY | 44.61% |
| 2020 | 1.32 Billion CNY | 109.64% |
| 2019 | 631.48 Million CNY | 66.16% |
| 2018 | 380.04 Million CNY | 44.52% |
| 2017 | 262.96 Million CNY | 38.52% |
| 2016 | 189.83 Million CNY | 160.36% |
| 2015 | 72.91 Million CNY | 196.21% |
| 2014 | 24.61 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 397.99 Million CNY | 8.54% |
| 2024 Q1 | 288.34 Million CNY | -27.72% |
| 2024 Q2 | 366.69 Million CNY | 27.17% |
| 2023 FY | 1.68 Billion CNY | -0.01% |
| 2023 Q3 | 414.6 Million CNY | -14.04% |
| 2023 Q2 | 482.3 Million CNY | 11.76% |
| 2023 Q1 | 431.57 Million CNY | -7.56% |
| 2023 Q4 | 398.94 Million CNY | -3.78% |
| 2022 Q1 | 320.06 Million CNY | -54.81% |
| 2022 Q3 | 373.41 Million CNY | -12.93% |
| 2022 Q4 | 466.88 Million CNY | 25.03% |
| 2022 FY | 1.68 Billion CNY | -11.72% |
| 2022 Q2 | 428.87 Million CNY | 34.0% |
| 2021 Q3 | 536.34 Million CNY | 38.74% |
| 2021 Q4 | 708.31 Million CNY | 32.06% |
| 2021 Q1 | 283.09 Million CNY | -33.56% |
| 2021 FY | 1.91 Billion CNY | 44.61% |
| 2021 Q2 | 386.58 Million CNY | 36.56% |
| 2020 Q3 | 361.18 Million CNY | -13.53% |
| 2020 Q2 | 417.69 Million CNY | 251.31% |
| 2020 Q1 | 118.89 Million CNY | -54.91% |
| 2020 FY | 1.32 Billion CNY | 109.64% |
| 2020 Q4 | 426.06 Million CNY | 17.96% |
| 2019 Q4 | 263.66 Million CNY | 42.35% |
| 2019 Q3 | 185.22 Million CNY | 53.21% |
| 2019 Q2 | 120.89 Million CNY | 95.96% |
| 2019 Q1 | 61.69 Million CNY | -45.05% |
| 2019 FY | 631.48 Million CNY | 66.16% |
| 2018 Q4 | 112.28 Million CNY | -9.74% |
| 2018 FY | 380.04 Million CNY | 44.52% |
| 2018 Q3 | 124.4 Million CNY | 29.43% |
| 2018 Q2 | 96.11 Million CNY | 105.39% |
| 2018 Q1 | 46.79 Million CNY | -45.51% |
| 2017 Q4 | 85.88 Million CNY | 0.0% |
| 2017 FY | 262.96 Million CNY | 38.52% |
| 2016 FY | 189.83 Million CNY | 160.36% |
| 2015 FY | 72.91 Million CNY | 196.21% |
| 2014 FY | 24.61 Million CNY | 0.0% |